Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Meeting of the Board of Directors of the Company ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Directors of Covidh Technologies Ltd, at its meeting on March 10, 2026, approved several key corporate actions. The company proposes to change its name from 'Covidh Technologies Limited' to 'iSERA Lifesciences Limited,' subject to shareholder approval by special resolution. The registered office is being shifted within Pune from Shukrawar Peth to Sadhu Vaswani Chowk, Camp, effective the same day. The Board also recommended appointing Mr. Dhairyasheel Vasantrao Yadav and Mr. Nandkumar Subhash Kadam as Executive Directors, and Mr. Pratap Dadasaheb Deshmukh and Ms. Ritu Dhanraj Garad as Non-Executive Directors, each for a five-year term pending shareholder approval. An Extraordinary General Meeting (EGM) has been scheduled for April 2, 2026, to seek member approval for these matters.
The rebranding to 'iSERA Lifesciences' signals a strategic pivot toward the pharmaceutical/biotech sector, aligned with the incoming directors' pharma and biotech backgrounds. Shareholders should watch for the EGM outcome on April 2, 2026, as the name change and director appointments could influence the company's future direction and market positioning.